311 related articles for article (PubMed ID: 25935883)
21. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
Maron MS; Maron BJ; Harrigan C; Buros J; Gibson CM; Olivotto I; Biller L; Lesser JR; Udelson JE; Manning WJ; Appelbaum E
J Am Coll Cardiol; 2009 Jul; 54(3):220-8. PubMed ID: 19589434
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and predictors of asymmetric hypertensive heart disease: insights from cardiac and aortic function with cardiovascular magnetic resonance.
Rodrigues JC; Amadu AM; Dastidar AG; Hassan N; Lyen SM; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
Eur Heart J Cardiovasc Imaging; 2016 Dec; 17(12):1405-1413. PubMed ID: 26705488
[TBL] [Abstract][Full Text] [Related]
23. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients.
Kim EK; Lee SC; Hwang JW; Chang SA; Park SJ; On YK; Park KM; Choe YH; Kim SM; Park SW; Oh JK
Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):678-86. PubMed ID: 26245912
[TBL] [Abstract][Full Text] [Related]
24. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P
Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599
[TBL] [Abstract][Full Text] [Related]
25. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
Olivotto I; Maron MS; Adabag AS; Casey SA; Vargiu D; Link MS; Udelson JE; Cecchi F; Maron BJ
J Am Coll Cardiol; 2005 Aug; 46(3):480-7. PubMed ID: 16053962
[TBL] [Abstract][Full Text] [Related]
26. CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.
Cheng S; Choe YH; Ota H; Cui C; Yin G; Lu M; Li L; Chen X; Prasad SK; Zhao S
Int J Cardiovasc Imaging; 2018 Apr; 34(4):597-605. PubMed ID: 29071521
[TBL] [Abstract][Full Text] [Related]
27. Right ventricular myocardial involvement in either physiological or pathological left ventricular hypertrophy: an ultrasound speckle-tracking two-dimensional strain analysis.
D'Andrea A; Caso P; Bossone E; Scarafile R; Riegler L; Di Salvo G; Gravino R; Cocchia R; Castaldo F; Salerno G; Golia E; Limongelli G; De Corato G; Cuomo S; Pacileo G; Russo MG; Calabrò R
Eur J Echocardiogr; 2010 Jul; 11(6):492-500. PubMed ID: 20551250
[TBL] [Abstract][Full Text] [Related]
28. Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy.
Conte MR; Bongioanni S; Chiribiri A; Leuzzi S; Lardone E; Di Donna P; Pizzuti A; Luceri S; Cesarani F; Mabritto B; Zoccai GB; Bonamini R; Gaita F
Am Heart J; 2011 Jun; 161(6):1073-7. PubMed ID: 21641353
[TBL] [Abstract][Full Text] [Related]
29. The prognostic role of right ventricular dysfunction in patients with hypertrophic cardiomyopathy.
Mushtaq S; Monti L; Rossi A; Pontone G; Conte E; Nicoli F; di Odoardo L; Guglielmo M; Indolfi E; Bombace S; Baggiano A; Gripari P; Pepi M; Bartorelli A; Oliveira M; Santos A; Francone M; Andreini D
Int J Cardiovasc Imaging; 2023 Aug; 39(8):1515-1523. PubMed ID: 37147451
[TBL] [Abstract][Full Text] [Related]
30. Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.
Lyons KS; Dixon LJ; Johnston N; Noad R; Hamilton A; McKeag N; Horan P
Cardiol J; 2014; 21(1):29-32. PubMed ID: 23990187
[TBL] [Abstract][Full Text] [Related]
31. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy.
Chaowu Y; Shihua Z; Jian L; Li L; Wei F
Circ Heart Fail; 2013 Sep; 6(5):1013-20. PubMed ID: 23873474
[TBL] [Abstract][Full Text] [Related]
33. Unravelling the grey zone: cardiac MRI volume to wall mass ratio to differentiate hypertrophic cardiomyopathy and the athlete's heart.
Luijkx T; Cramer MJ; Buckens CF; Zaidi A; Rienks R; Mosterd A; Prakken NH; Dijkman B; Mali WP; Velthuis BK
Br J Sports Med; 2015 Nov; 49(21):1404-9. PubMed ID: 23770661
[TBL] [Abstract][Full Text] [Related]
34. Comparison of resting and exercise echocardiographic parameters as indicators of outcomes in hypertrophic cardiomyopathy.
Reant P; Reynaud A; Pillois X; Dijos M; Arsac F; Touche C; Landelle M; Rooryck C; Roudaut R; Lafitte S
J Am Soc Echocardiogr; 2015 Feb; 28(2):194-203. PubMed ID: 25459499
[TBL] [Abstract][Full Text] [Related]
35. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
[TBL] [Abstract][Full Text] [Related]
36. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy.
Peteiro J; Bouzas-Mosquera A; Fernandez X; Monserrat L; Pazos P; Estevez-Loureiro R; Castro-Beiras A
J Am Soc Echocardiogr; 2012 Feb; 25(2):182-9. PubMed ID: 22137254
[TBL] [Abstract][Full Text] [Related]
38. Right-ventricular mechanics assessed by cardiovascular magnetic resonance feature tracking in children with hypertrophic cardiomyopathy.
Petryka-Mazurkiewicz J; Ziolkowska L; Mazurkiewicz Ł; Kowalczyk-Domagała M; Boruc A; Śpiewak M; Marczak M; Brzezinska-Rajszys G
PLoS One; 2021; 16(3):e0248725. PubMed ID: 33735278
[TBL] [Abstract][Full Text] [Related]
39. [Comparison on CMR characteristics and clinical prognosis between hypertrophic cardiomyopathy patients with and without left ventricular apical aneurysms].
Song YY; Lu MJ; Li L; Cui C; Cheng HB; Chen XY; Yin G; Zhao SH
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Mar; 47(3):204-208. PubMed ID: 30897879
[No Abstract] [Full Text] [Related]
40. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
